Boehringer Ingelheim expects its investments in sustainability initiatives and health partnerships to reach €500 million by the end of 2026, as the company steps up efforts to strengthen healthcare systems and expand access to health solutions for people and communities.

 

The company announced the projection at its “Making More Health Together” Convention in Ingelheim, where more than 400 health entrepreneurs, investors and healthcare-system partners have gathered under the theme “Make it real.”

 

At the centre of the company’s efforts is the Boehringer Ingelheim Social Engagement Fund (BISE), a €50 million impact-financing initiative focused on strengthening healthcare systems. About 80% of the fund has already been committed, supporting 27 social start-ups — 24 in Africa and three in Latin America — working across primary care, health insurance, diagnostics, telehealth, mobile clinics and last-mile medicine delivery.

 

Another 38 companies have received support to prepare for potential funding. Collectively, the portfolio companies are projected to surpass Boehringer Ingelheim’s original 2021 ambition of improving the lives of 50 million people.

 

“As a family-owned company, we think in generations, not in quarters and we have seen that many promising ideas begin with the potential to transform lives—but their impact remains limited, unless they can scale. Scaling requires more than capital; it depends on strong networks, the right partners and access to expertise. 

 

"That is why, together with our long-standing partners, we created Making More Health Together: to connect entrepreneurs, investors and businesses and turn promising solutions into impact. For me, any initiative in corporate sustainability needs to align with the company strategy and is part of how we innovate, invest and make decisions—so that societal impact and business success mutually reinforce each other”, said Hubertus von Baumbach, Chairman of the Boehringer Ingelheim Shareholders’ Committee.

 

Established in 2021, the BISE Fund was created to address a financing gap faced by social start-ups seeking to scale healthcare solutions. The model combines impact-first financing with business expertise, technical assistance and access to networks, giving entrepreneurs capital alongside the partnerships and expertise needed to expand.

 

The company pointed to several portfolio companies as examples of the model’s reach.

 

In Kenya, Zuri Health provides primary care to underserved communities through telemedicine and mobile clinics and has reached more than six million people. ThinkMD, meanwhile, uses an AI-supported clinical decision tool to help frontline health workers diagnose and triage patients. The solution is now operational in seven countries and has reached more than three million people.

 

In Romania, Boehringer Ingelheim is working with NGO Caravana cu Medici to bring screening and diagnosis to rural communities, where the company says one in two people are not diagnosed in time.

 

Boehringer Ingelheim says these initiatives demonstrate how underserved communities can serve not only as beneficiaries of healthcare innovation, but also as sources of solutions that can inform health systems globally.

 

Boehringer Ingelheim is now preparing the next phase of the Social Engagement Fund. The company expects around 50–75% of the financing provided to be repaid from 2032 onwards, with plans to reinvest those returns in a new generation of health entrepreneurs.

 

The strategy would turn the fund into a more self-sustaining impact-financing platform, while linking it more closely with Boehringer Ingelheim’s broader health programmes.

 

These include CRM Patient Africa and the Angels Initiative, which focuses on preventing stroke and improving stroke care. The Angels Initiative has reached more than 28 million patients across more than 180 countries, according to the company.

 

By connecting entrepreneurs with financing as well as clinical expertise, distribution networks and policymakers, Boehringer Ingelheim aims to extend the reach of its health partnerships and accelerate the scale-up of solutions targeting underserved populations.